| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.31B | 100.33B | 95.90B | 91.57B | 86.29B | 85.81B |
| Gross Profit | 26.14B | 25.34B | 24.10B | 22.32B | 21.33B | 22.34B |
| EBITDA | 4.45B | 4.31B | 4.06B | 3.01B | 3.41B | 3.59B |
| Net Income | 2.76B | 2.61B | 2.16B | 1.45B | 1.65B | 1.44B |
Balance Sheet | ||||||
| Total Assets | 50.79B | 50.85B | 51.26B | 48.76B | 46.32B | 43.19B |
| Cash, Cash Equivalents and Short-Term Investments | 29.00B | 27.84B | 29.15B | 27.17B | 25.50B | 22.85B |
| Total Debt | 11.35B | 9.80B | 10.62B | 11.27B | 10.84B | 8.46B |
| Total Liabilities | 33.07B | 32.75B | 35.13B | 34.05B | 32.70B | 30.73B |
| Stockholders Equity | 17.72B | 18.10B | 16.13B | 14.72B | 13.63B | 12.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 558.42M | 3.89B | 1.83B | 1.11B | 1.22B |
| Operating Cash Flow | 0.00 | 1.52B | 4.62B | 2.53B | 1.83B | 2.05B |
| Investing Cash Flow | 0.00 | -1.38B | -1.23B | -1.03B | -1.27B | -1.02B |
| Financing Cash Flow | 0.00 | -1.46B | -1.43B | -114.84M | 2.10B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥18.01B | 13.55 | ― | 3.81% | 9.96% | 252.72% | |
75 Outperform | ¥58.88B | 18.77 | ― | 2.94% | 16.32% | 23.04% | |
75 Outperform | ¥44.17B | 28.75 | ― | 2.28% | 7.30% | 60.93% | |
74 Outperform | ¥17.94B | 7.46 | ― | 3.47% | 4.22% | 27.56% | |
70 Outperform | ¥38.05B | 18.91 | ― | 2.56% | 7.41% | 22.70% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥13.47B | 36.70 | ― | 0.84% | 8.44% | 17.98% |